Acquired
Novo Nordisk (Ozempic)
Ben Gilbert
Well, before we go into analysis, there is a little bit of catching up to do on the insulin market because we kind of left it as, hey, it's still 22% of revenue in Novo's business and, you know, big three companies, Sanofi and Eli Lilly and Novo really compete here and they've iterated to become great products over time.
0
💬
0
Comments
Log in to comment.
There are no comments yet.